{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:32:23Z","timestamp":1792186343668,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Funds for the Innovation of Science and Technology, Fujian province","award":["2023Y9313"],"award-info":[{"award-number":["2023Y9313"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101893"],"award-info":[{"award-number":["82101893"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2023GGA008"],"award-info":[{"award-number":["2023GGA008"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of  Fujian","award":["2023J011178"],"award-info":[{"award-number":["2023J011178"]}]},{"name":"the First Affiliated Hospital of Soochow University BOXI Clinical Research Project","award":["BXLC016"],"award-info":[{"award-number":["BXLC016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10067-024-07103-2","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T12:02:21Z","timestamp":1723550541000},"page":"3139-3145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tofacitinib therapy in systemic lupus erythematosus with arthritis: a retrospective study"],"prefix":"10.1007","volume":"43","author":[{"given":"Qing","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenmin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diantian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9684-9739","authenticated-orcid":false,"given":"Ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"issue":"6","key":"7103_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrrheum.2010.60","volume":"6","author":"JC Crisp\u00edn","year":"2010","unstructured":"Crisp\u00edn JC, Kyttaris VC, Terhorst C, Tsokos GC (2010) T cells as therapeutic targets in SLE. Nat Rev Rheumatol 6(6):317\u2013325","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"7103_CR2","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1172\/JCI78087","volume":"125","author":"VR Moulton","year":"2015","unstructured":"Moulton VR, Tsokos GC (2015) T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J Clin Invest 125(6):2220\u20132227","journal-title":"J Clin Invest"},{"issue":"6","key":"7103_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrrheum.2010.64","volume":"6","author":"L R\u00f6nnblom","year":"2010","unstructured":"R\u00f6nnblom L, Elkon KB (2010) Cytokines as therapeutic targets in SLE. Nat Rev Rheumatol 6(6):339\u2013347","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"7103_CR4","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN et al (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78(6):736\u2013745","journal-title":"Ann Rheum Dis"},{"key":"7103_CR5","doi-asserted-by":"publisher","first-page":"675542","DOI":"10.3389\/fimmu.2021.675542","volume":"12","author":"Q Yan","year":"2021","unstructured":"Yan Q, Chen W, Song H, Long X, Zhang Z, Tang X et al (2021) Tofacitinib ameliorates lupus through suppression of T cell activation mediated by TGF-beta type I receptor. Front Immunol 12:675542","journal-title":"Front Immunol"},{"issue":"1","key":"7103_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/13543784.2019.1551358","volume":"28","author":"CC Mok","year":"2019","unstructured":"Mok CC (2019) The Jakinibs in systemic lupus erythematosus: progress and prospects. Expert Opin Investig Drugs 28(1):85\u201392","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"7103_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/art.39818","volume":"69","author":"Y Furumoto","year":"2017","unstructured":"Furumoto Y, Smith CK, Blanco L, Zhao W, Brooks SR, Thacker SG et al (2017) Tofacitinib ameliorates murine lupus and its associated vascular dysfunction. Arthritis Rheumatol 69(1):148\u2013160","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"7103_CR8","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/annrheumdis-2019-215455","volume":"78","author":"H You","year":"2019","unstructured":"You H, Zhang G, Wang Q, Zhang S, Zhao J, Tian X et al (2019) Successful treatment of arthritis and rash with tofacitinib in systemic lupus erythematosus: the experience from a single centre. Ann Rheum Dis 78(10):1441\u20131443","journal-title":"Ann Rheum Dis"},{"issue":"10381","key":"7103_CR9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0140-6736(22)02607-1","volume":"401","author":"EF Morand","year":"2023","unstructured":"Morand EF, Vital EM, Petri M, van Vollenhoven R, Wallace DJ, Mosca M et al (2023) Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I). Lancet 401(10381):1001\u20131010","journal-title":"Lancet"},{"issue":"10143","key":"7103_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0140-6736(18)31363-1","volume":"392","author":"DJ Wallace","year":"2018","unstructured":"Wallace DJ, Furie RA, Tanaka Y, Kalunian KC, Mosca M, Petri MA et al (2018) Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 392(10143):222\u2013231","journal-title":"Lancet"},{"issue":"10381","key":"7103_CR11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(22)02546-6","volume":"401","author":"M Petri","year":"2023","unstructured":"Petri M, Bruce IN, D\u00f6rner T, Tanaka Y, Morand EF, Kalunian KC et al (2023) Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II). Lancet 401(10381):1011\u20131019","journal-title":"Lancet"},{"issue":"3","key":"7103_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","volume":"76","author":"R van Vollenhoven","year":"2017","unstructured":"van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L et al (2017) A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). Ann Rheum Dis 76(3):554\u2013561","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7103_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4078\/jrd.2022.29.1.22","volume":"29","author":"SJ Choi","year":"2022","unstructured":"Choi SJ, Ahn SM, Oh JS, Hong S, Lee CK, Yoo B, Kim YG (2022) Initial preserved renal function as a predictor of favorable renal response to rituximab in refractory or relapsing lupus nephritis: a single-center cohort study in Korea. J Rheum Dis 29(1):22\u201332","journal-title":"J Rheum Dis"},{"issue":"3","key":"7103_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4078\/jrd.2021.28.3.133","volume":"28","author":"WY Baek","year":"2021","unstructured":"Baek WY, Lee SM, Lee SW, Son IO, Choi S, Suh CH (2021) Intravenous administration of toll-like receptor inhibitory peptide 1 is effective for the treatment of systemic lupus erythematosus in a mus musculus model. J Rheum Dis 28(3):133\u2013142","journal-title":"J Rheum Dis"},{"issue":"22","key":"7103_CR15","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365(22):2110\u20132121","journal-title":"N Engl J Med"},{"issue":"2","key":"7103_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10067-023-06731-4","volume":"43","author":"BE Amer","year":"2024","unstructured":"Amer BE, Afifi E, Mouffokes A, Hamad AA, Amin AM, Abdelwahab OA (2024) Does baricitinib reduce disease activity in patients with systemic lupus erythematosus? A systematic review and meta-analysis of randomized controlled trials. Clin Rheumatol 43(2):579\u2013589","journal-title":"Clin Rheumatol"},{"issue":"9","key":"7103_CR17","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/acr.22299","volume":"66","author":"M Urowitz","year":"2014","unstructured":"Urowitz M, Gladman DD, Iba\u00f1ez D, Sanchez-Guerrero J, Bae SC, Gordon C et al (2014) Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 66(9):1374\u20131379","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"7103_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/acr.20648","volume":"64","author":"MB Urowitz","year":"2012","unstructured":"Urowitz MB, Gladman DD, Iba\u00f1ez D, Fortin PR, Bae SC, Gordon C et al (2012) Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken) 64(1):132\u2013137","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"7103_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.semarthrit.2011.12.005","volume":"42","author":"M Jolly","year":"2012","unstructured":"Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT et al (2012) Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum 42(1):56\u201365","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"7103_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/0961203316659546","volume":"26","author":"LN Moorthy","year":"2017","unstructured":"Moorthy LN, Baldino ME, Kurra V, Puwar D, Llanos A, Peterson MG et al (2017) Relationship between health-related quality of life, disease activity and disease damage in a prospective international multicenter cohort of childhood onset systemic lupus erythematosus patients. Lupus 26(3):255\u2013265","journal-title":"Lupus"},{"issue":"7","key":"7103_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/1744666X.2019.1608821","volume":"15","author":"S Kubo","year":"2019","unstructured":"Kubo S, Nakayamada S, Tanaka Y (2019) Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update. Expert Rev Clin Immunol 15(7):693\u2013700","journal-title":"Expert Rev Clin Immunol"},{"issue":"6681","key":"7103_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1126\/science.adf8531","volume":"383","author":"D Dai","year":"2024","unstructured":"Dai D, Gu S, Han X, Ding H, Jiang Y, Zhang X et al (2024) The transcription factor ZEB2 drives the formation of age-associated B cells. Science 383(6681):413\u2013421","journal-title":"Science"},{"issue":"12","key":"7103_CR23","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1177\/0961203311409963","volume":"20","author":"M Kawasaki","year":"2011","unstructured":"Kawasaki M, Fujishiro M, Yamaguchi A, Nozawa K, Kaneko H, Takasaki Y et al (2011) Possible role of the JAK\/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus. Lupus 20(12):1231\u20131239","journal-title":"Lupus"},{"key":"7103_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102424","volume":"109","author":"M Zhou","year":"2020","unstructured":"Zhou M, Guo C, Li X, Huang Y, Li M, Zhang T et al (2020) JAK\/STAT signaling controls the fate of CD8(+)CD103(+) tissue-resident memory T cell in lupus nephritis. J Autoimmun 109:102424","journal-title":"J Autoimmun"},{"issue":"11","key":"7103_CR25","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1007\/s12325-022-02281-4","volume":"39","author":"T Bieber","year":"2022","unstructured":"Bieber T, Feist E, Irvine AD, Harigai M, Haladyj E, Ball S et al (2022) A review of safety outcomes from clinical trials of baricitinib in rheumatology, dermatology and COVID-19. Adv Ther 39(11):4910\u20134960","journal-title":"Adv Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07103-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07103-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07103-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:07:05Z","timestamp":1727672825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07103-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["7103"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07103-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Fujian Provincial Hospital (No. K2020-03\u2013014). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}